Şahin Ertan, Elboğa Umut
Department of Nuclear Medicine, Namık Kemal University Hospital, Tekirdağ, Turkey.
Department of Nuclear Medicine, Gaziantep University Hospital, Gaziantep, Turkey.
Radiol Med. 2017 Oct;122(10):785-792. doi: 10.1007/s11547-017-0779-x. Epub 2017 Jun 9.
The reticuloendothelial system (RES) is a part of the immune system and plays a major role in the protection of against diseases. We thought that FDG-PET/CT may show the degree of systemic immune response induced with malignancy in the organs with the high RES activity. Our objective is to investigate FDG uptake levels of high RES activity organs (liver, spleen, bone marrow) in invasive ductal breast cancer and to evaluate the association with the clinicopathological features.
In the present study, 193 patients with invasive ductal breast cancer who performed FDG-PET/CT were categorized according to the clinicopathological features including age, tumor size, axillary nodal status, histological grade, the presence of lymphavascular invasion, receptor status, Ki-67 proliferation index and biological subgroup. Also, a control group of 100 subjects were identified for comparison with breast cancer patients. We analyzed the relation of FDG uptake levels in high RES activity organs and clinicopathological features in patients.
There was a statistically significant difference of SUVmax of the liver, spleen, and bone marrow between cancer and control groups (P < 0.0001). We found that high SUVmax in liver, spleen and bone marrow were significantly correlated with worse prognostic clinicopathological features in patient with invasive ductal breast cancer.
FDG uptake level in high RES activity organs is associated with the presence of tumor, and also directly relating clinicopathological features for patients with invasive ductal breast cancer.
网状内皮系统(RES)是免疫系统的一部分,在抵御疾病方面发挥着重要作用。我们认为,氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)可能显示出RES活性高的器官中由恶性肿瘤诱导的全身免疫反应程度。我们的目的是研究浸润性导管癌中RES活性高的器官(肝脏、脾脏、骨髓)的FDG摄取水平,并评估其与临床病理特征的相关性。
在本研究中,193例行FDG-PET/CT检查的浸润性导管癌患者根据年龄、肿瘤大小、腋窝淋巴结状态、组织学分级、淋巴管浸润情况、受体状态、Ki-67增殖指数和生物学亚组等临床病理特征进行分类。此外,还确定了100名受试者作为对照组与乳腺癌患者进行比较。我们分析了患者RES活性高的器官中FDG摄取水平与临床病理特征之间的关系。
癌症组与对照组肝脏、脾脏和骨髓的最大标准摄取值(SUVmax)存在统计学显著差异(P < 0.0001)。我们发现,浸润性导管癌患者肝脏、脾脏和骨髓中高SUVmax与较差的预后临床病理特征显著相关。
RES活性高的器官中的FDG摄取水平与肿瘤存在相关,并且与浸润性导管癌患者的临床病理特征直接相关。